Table 2.
Hemodynamic variables of study patients
Baseline | 12 hours | P value | |
Pulmonary artery occlusion pressure (mmHg) | 1.000 | ||
Phenylephrine | 15 ± 2 | 17 ± 3* | |
Norepinephrine | 15 ± 2 | 17 ± 3* | |
Right atrial pressure (mmHg) | 0.902 | ||
Phenylephrine | 13 ± 3 | 15 ± 3* | |
Norepinephrine | 13 ± 3 | 14 ± 3* | |
Mean pulmonary arterial pressure (mmHg) | 0.521 | ||
Phenylephrine | 28 ± 9 | 33 ± 11* | |
Norepinephrine | 27 ± 5 | 30 ± 4* | |
Pulmonary vascular resistance index (dyne·s/cm5/m2) | 0.330 | ||
Phenylephrine | 293 ± 253 | 348 ± 296* | |
Norepinephrine | 235 ± 103 | 264 ± 105 | |
Right ventricular stroke work index (g/m2/beat) | 0.564 | ||
Phenylephrine | 9 ± 5 | 12 ± 7* | |
Norepinephrine | 8 ± 4 | 11 ± 4* | |
Left ventricular stroke work index (g/m2/beat) | 0.721 | ||
Phenylephrine | 25 ± 11 | 35 ± 14* | |
Norepinephrine | 25 ± 8 | 37 ± 9* | |
Stroke volume index (g/m2/beat) | 0.963 | ||
Phenylephrine | 45 ± 18 | 49 ± 19 | |
Norepinephrine | 46 ± 13 | 50 ± 11 | |
Cardiac troponin I (ng/ml) | 0.854 | ||
Phenylephrine | 1.0 ± 0.9 | 1.1 ± 0.9 | |
Norepinephrine | 0.9 ± 0.9 | 1.1 ± 0.8 |
*P < 0.05 versus baseline (significant time effect).